Artwork for podcast CFO THOUGHT LEADER
335: Garnering Investor Recognition | Josh Blacher, CFO of Therapix Biosciences
18th October 2017 • CFO THOUGHT LEADER • The Future of Finance is Listening
00:00:00 00:29:35

Share Episode

Shownotes

A brief summary of this episode

Follow

Links

Chapters

Video

More from YouTube